TrialClinical ophthalmology (Auckland, N.Z.)2020
Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label Study.
Masumi G Asahi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.